Catalio Capital Management, LP vs General Catalyst
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Catalio Capital Management, LP | General Catalyst | |
|---|---|---|
| Type | Crossover fund | Venture capital |
| HQ | New York | San Francisco |
| Founded | 2020 | 2000 |
| Check size | β | $30M |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Digital Health, Healthtech, Longevity, Medical Devices | Advanced Manufacturing, AI & Machine Learning, Biotech, Consumer, Defense Tech, Digital Health, E-commerce, Energy, Enterprise Software, Fintech, Hardware, Healthtech, Sector Agnostic, Travel & Hospitality |
| AUM | $2.2B | $45.5B |
| Tracked investments | 106 | 211 |
| Exits (acquired/public) | 2 | 7 |
| Led rounds on record | β | 17 |
| Dated deals, last 24 mo | 3 | 21 |
Shared portfolio Β· 5
ArriVent BioPharmaBeacon BiosignalsHippocratic AIParabilis MedicinesElektrofi
Frequently asked questions
- Do Catalio Capital Management, LP and General Catalyst invest together?
- Yes β Catalio Capital Management, LP and General Catalyst appear together in 5 tracked portfolio companies, including ArriVent BioPharma, Beacon Biosignals, Hippocratic AI, Parabilis Medicines, Elektrofi.